Dr. Aljobori is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
St. David's North Austin Medical Center
12221 N. Mopac Expy
Austin, TX 78758
Summary
- Internal Medicine, Hospitalist
Education & Training
University of Texas RGV (VBMC)Residency, Internal Medicine, 2017 - 2020
OtherClass of 2008
Certifications & Licensure
MA State Medical License 2020 - 2025
TX State Medical License 2022 - 2025- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 48 citationsEmpagliflozin and Kinetics of Renal Glucose Transport in Healthy Individuals and Individuals With Type 2 Diabetes.Hussein Al-Jobori, Giuseppe Daniele, Eugenio Cersosimo, Curtis L Triplitt, Rucha J. Mehta
Diabetes. 2017-07-01 - 61 citationsEmpagliflozin Treatment Is Associated With Improved β-Cell Function in Type 2 Diabetes Mellitus.Hussein Al Jobori, Giuseppe Daniele, John Adams, Eugenio Cersosimo, Carolina Solis-Herrera
The Journal of Clinical Endocrinology and Metabolism. 2018-04-01 - 26 citationsCombination Therapy With Canagliflozin Plus Liraglutide Exerts Additive Effect on Weight Loss, but Not on HbA1c, in Patients With Type 2 Diabetes.Ali M. Ali, Robert A. Martinez, Robert A. Martinez, Hussein Al-Jobori, John Adams
Diabetes Care. 2020-03-20
Research History
- Postdoctoral fellowUT medicine San Antonio2015 - 2017
Professional Memberships
- Member
Other Languages
- Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
